C-BE4ZChrysea Labs
precision nutrition, synthetic biology, clinical research
consumer products
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-BE4Z
C-BE4ZC-BE4Zprecision nutrition, synthetic biology, clinical research
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Chrysea Labs precision nutrition, synthetic biology, clinical research
Chrysea is an early-commercial stage company developing precision nutrition interventions aimed at enhancing healthy lifespans. The company operates at the intersection of biology, bioengineering, clinical research and data analytics. Its interventions target condition-specific consumer health benefits and chronic health conditions associated with ageing.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Chrysea Labs — Early mechanism · Lower middle. Derived deterministically from 4 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic